These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 6890810

  • 1. [A clinical model for regulation of the humoral immune response].
    Fateh-Moghadam A, Besinger U, Geursen RG.
    Beitr Infusionther Klin Ernahr; 1982; 9():69-79. PubMed ID: 6890810
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Recent developments in high-dose immunoglobulin therapy: therapeutic plasma exchange, autoimmune diseases].
    Kalden JR, Schranz W, Lösch G, Krapf F, Bartels O.
    Beitr Infusionther Klin Ernahr; 1982; 9():48-59. PubMed ID: 6216881
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. High-dose intravenous immunoglobulin in the management of myasthenia gravis.
    Bonaventura I, Ponseti J, Arnau E, Matias-Guiu J, Codina Puiggros A.
    Arch Intern Med; 1987 Feb; 147(2):207, 211. PubMed ID: 3813729
    [No Abstract] [Full Text] [Related]

  • 6. [Study of lichen planus by direct immunofluorescence (author's transl)].
    Kanitakis C, Chrysomallis F, Ktenides MA.
    Ann Dermatol Venereol; 1978 Jan; 105(1):75-8. PubMed ID: 348005
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [High-dose immunoglobulin therapy of chronic idiopathic thrombocytopenic purpura in adults].
    Schedel I, Plaumann G, Bodenstein H, Anagnou I, Baruth B, Peest D, Deicher H, Geursen RG.
    Beitr Infusionther Klin Ernahr; 1982 Jan; 9():60-8. PubMed ID: 6890809
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of Bioglobulin on the clinical course of selected diseases of viral and bacterial etiologies].
    Janeczko J, Olejnik Z, Lipowski D, Przyjałkowski W, Romanowska B.
    Przegl Epidemiol; 1991 Jan; 45(4):273-7. PubMed ID: 1841402
    [Abstract] [Full Text] [Related]

  • 11. [Structure and function of immunoglobulins].
    Seiler FR.
    Beitr Infusionther Klin Ernahr; 1982 Jan; 9():1-15. PubMed ID: 6816212
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Modulation of the humoral immune response by antibody-mediated antigen targeting to complement receptors and Fc receptors.
    Baiu DC, Prechl J, Tchorbanov A, Molina HD, Erdei A, Sulica A, Capel PJ, Hazenbos WL.
    J Immunol; 1999 Mar 15; 162(6):3125-30. PubMed ID: 10092761
    [Abstract] [Full Text] [Related]

  • 15. Humoral immunity in myasthenia gravis: biochemical characterization of acquired antireceptor antibodies and clinical correlations.
    Tindall RS.
    Ann Neurol; 1981 Nov 15; 10(5):437-47. PubMed ID: 7305297
    [Abstract] [Full Text] [Related]

  • 16. [Substitution with immunoglobulins in primary antibody deficiency syndrome].
    Morell A, Barandun S.
    Beitr Infusionther Klin Ernahr; 1982 Nov 15; 9():16-24. PubMed ID: 6756383
    [No Abstract] [Full Text] [Related]

  • 17. High-dose intravenous gammaglobulin for myasthenia gravis.
    Fateh-Moghadam A, Wick M, Besinger U, Geursen RG.
    Lancet; 1984 Apr 14; 1(8381):848-9. PubMed ID: 6200741
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Animal models of myasthenia gravis.
    Christadoss P, Poussin M, Deng C.
    Clin Immunol; 2000 Feb 14; 94(2):75-87. PubMed ID: 10637092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.